Last Updated : July 9, 2012
When patients present to the emergency department with chest pain, investigations are needed to rule out acute coronary syndrome and acute myocardial infarction. One of the investigations used is cardiac troponin. Cardiac troponin is a biomarker that indicates cardiac muscle damage.
The Canadian Agency for Drugs and Technologies in Health (CADTH) is undertaking an optimal use project that will include several components comparing conventional and high-sensitivity cardiac troponin assays:
The objective of this project is to determine, when evaluating patients presenting in the emergency department with chest pain,
The project aims to provide health professionals, policy-makers, and patients with the evidence-based resources they need to make informed decisions.
Subscribe to the CADTH E-Alert to stay informed about opportunities to provide feedback.